AVDL
Avadel Pharmaceuticals
AVDL
AVDL
169 hedge funds and large institutions have $715M invested in Avadel Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 26 closing their positions.
Holders
169
Holders Change
-3
Holders Change %
-1.74%
% of All Funds
2.27%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
26
Increased
69
Reduced
49
Closed
26
Calls
$2.07M
Puts
$2.08M
Net Calls
-$8K
Net Calls Change
+$1.73M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$49.2M |
2 |
2
BlackRock
New York
|
$60.2M |
3 |
TSC
3
Two Seas Capital
Rye,
New York
|
$54.5M |
4 |
TLP
4
Tri Locum Partners
New York
|
$8.98M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$19.2M |
Top Sellers
1 |
1
Janus Henderson Group
London,
United Kingdom
|
$98.5M |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$1.28M |
3 |
GJL
3
Gendell Jeffrey L
|
$45.8M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$13.5M |
5 |
5
UBS Group
Zurich,
Switzerland
|
$7.75M |